• Search History (Register)
  • MeSH Browser
  • [Clear]
    • Canada

Welcome to the international HTA database


Showing [3321 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Treatments for patients with genotype 1 chronic hepatitis C: a review of evidence-based guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Automated notification and reminder call systems: guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Administration of naloxone in a home or community setting: a review of the clinical effectiveness, cost-effectiveness, and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Continuous positive airway pressure for acute respiratory failure in the pre-hospital setting: guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Long-term 5HT3 antagonist use for alcohol dependence: clinical evidence and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Management of massive blood transfusion in the rural setting: guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Cryotherapy systems for wart removal: a review of the clinical effectiveness, cost-effectiveness, and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Jewellery and the risk of bacteria transmission from healthcare worker to patient: clinical evidence
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Intranasal versus intravenous naloxone for opioid overdose in the pre-hospital setting: comparative clinical effectiveness
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Intrathecal bupivacaine via infusion pump for the management of pain: clinical evidence, safety, and guidelines
2014     HTA Unit, University of Calgary Repetitive transcranial magnetic stimulation for treatment resistant depression
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Electromagnetic interference between healthcare laser systems and sensitive electronic devices: safety and guidelines
2014     HTA Unit, University of Calgary Best practices in the management of behavioural and psychological symptoms of dementia in residents of long-term care facilities in Alberta
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Radiation emissions from computed tomography: a review of the risk of cancer and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Magnetic resonance imaging for patients with surgically implanted devices: safety and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Waterless wipes for chemical eye injuries: clinical effectiveness
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Fentanyl transdermal patches in palliative care: clinical effectiveness, safety, and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Therapeutic recreation for elderly and mental health patients: clinical benefit, safety, and guidelines
2014     Institut national d'excellence en sante et en services sociaux (INESSS) [Judicious use of 14 laboratory tests]
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Emergency medical service "treat and release" protocols: a review of clinical and cost-effectiveness, safety, and guidelines
2014     Institut national d'excellence en sante et en services sociaux (INESSS) [ETIAMEST I & II: Highlights]
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Balloon gastrostomy devices for adults: guidelines for replacement, maintenance, and training
2014     Institut national d'excellence en sante et en services sociaux (INESSS) [Facility planning and infection prevention: sanitary facilities in specialized care rooms and cubicles]
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Electric shocks from conducted electric weapons: long-term clinical effects and guidelines for medical follow-up
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Autologous fat grafting for reconstructive surgery: a review of the clinical and cost-effectiveness
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Oral intake in critical care patients: guidelines and recommendations
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Capnography and/or oximetry monitoring of patients using patient-controlled intravenous opioids: clinical and cost-effectiveness, safety, and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Periodic dental examinations for oral health: a review of clinical effectiveness, cost effectiveness, and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Dehumidifiers for reduction of humidity in operating rooms: clinical effectiveness and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Personal wireless device use for wound care consultation: a review of safety, clinical benefits and guidelines
2014     Institute of Health Economics (IHE) Low dose computed tomography for the screening of lung cancer in adults
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) High-fidelity simulation training for health care professionals: cost effectiveness and guidelines
2014     Institute of Health Economics (IHE) First and second trimester prenatal screening update
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Mattresses for chronic back or neck pain: a review of the clinical effectiveness and guidelines
2014     Institute of Health Economics (IHE) Endovenous ablation interventions for symptomatic varicose veins of the legs
2014     Technology Assessment at SickKids (TASK) The cost-effectiveness of clinic-based chloral hydrate sedation versus general anaesthesia for paediatric ophthalmological procedures
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Appropriate use of hand-held wireless devices in healthcare settings: guidelines
2014     Institute of Health Economics (IHE) Hysteroscopic tubal sterilization
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Bivalirudin infusion following angioplasty: safety
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Stepwise approach for the prescription of opiates for non-cancer pain: a review of clinical evidence and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Nebulizers for the methacholine challenge test: diagnostic accuracy and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Intra-aortic balloon pumps for cardiac conditions: guidelines
2014     Institut national d'excellence en sante et en services sociaux (INESSS) [Efficiency of the "housing first" approach for people who are homeless and living with mental illness or with disorders associated to psychoactive substances]
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Delivery of electroconvulsive therapy in non-hospital settings: a review of the safety and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Personal protection for visitors to patients on airborne precautions: clinical effectiveness and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Sterilization of gauze for surgical procedures: clinical effectiveness, harms, and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Lifestyle prescriptions: a review of the clinical evidence
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Home isolation to prevent tuberculosis transmission: a review of the clinical evidence and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Equipment required for medication nebulization: safety and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Fall prevention strategies for adults in outpatient programs: clinical evidence and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Mobile apps for improving health: clinical evidence
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Non-manual techniques for room disinfection in healthcare facilities: a review of clinical effectiveness and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Contact investigations following patient and staff exposure to active tuberculosis infections: a review of the clinical evidence and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Oral progesterone for the treatment of menopausal symptoms: a review of the clinical evidence
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Vaginal micronized progesterone capsules for the prevention of miscarriage and preterm birth: a review of the clinical evidence
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Direct acting antivirals for chronic hepatitis C genotype 1 in select populations: emerging evidence of clinical effectiveness and safety
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Closed Intensive Care Units: Clinical and Cost-Effectiveness, Safety, and Guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Bariatric surgical procedures for obese and morbidly obese patients: a review of comparative clinical and cost-effectiveness, and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Short-acting intramuscular olanzapine for acute agitation: clinical and cost - effectiveness and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Re-treatment with direct acting antivirals for chronic hepatitis C genotype 1: emerging evidence of clinical effectiveness and safety
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Long-term use of ondansetron, dolasetron and granisetron for the prevention of nausea and vomiting: a review of the clinical effectiveness and safety
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Reprocessing of single use medical devices: effectiveness, safety, and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Aspirating versus not aspirating prior to injection of medication: comparative clinical evidence and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) BMI reduction and chronic disease management: clinical evidence
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Providing rehabilitation services for seven days versus five days per week: clinical effectiveness and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Suspended ceiling lifts: safety
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) OnabotulinumtoxinA (Botox - Allergan Inc.) indication: chronic migraine
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Suctioning for respiratory blockage: clinical effectiveness and guidelines
2014     Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval) [Evaluation of measures related to the prevention of multiple falls in hospitalized elderly people]
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Rotigotine (Neupro - UCB Canada Inc.) indication: idiopathic Parkinson disease (early and advanced)
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Anesthetic injections into the stellate ganglion for the treatment of hot flashes in women: a review of clinical and cost-effectiveness and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Magnetic resonance imaging for patients with surgically implanted devices: safety and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Optimal oxygen saturation range for adults suffering from traumatic brain injury: a review of patient benefit, harms, and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Fentanyl transdermal patches in palliative care: clinical effectiveness, safety, and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Junctional tourniquets for controlling hemorrhage from wounds in adults: a review of clinical effectiveness, cost-effectiveness, safety, and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Electric shocks from conducted electric weapons: long-term clinical effects and guidelines for medical follow-up
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Antiemetics for adults experiencing opioid-induced nausea: a review of clinical and cost-effectiveness, benefits and harms, and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Balloon gastrostomy devices for adults: guidelines for replacement, maintenance, and training
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Hearing protection fit testing systems: clinical and cost-effectiveness and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Oral intake in critical care patients: guidelines and recommendations
2014     Technology Assessment Unit of the McGill University Health Centre (MUHC) Islet transplantation in patients with Type 1 Diabetes Mellitus
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Positive expiratory pressure devices and incentive spirometers for the prevention of pneumonia: comparative clinical effectiveness and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Pharmacologic and non-pharmacologic treatments for alcohol withdrawal in the outpatient setting: a review of the clinical effectiveness, cost-effectiveness, and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Capnography and/or oximetry monitoring of patients using patient-controlled intravenous opioids: clinical and cost-effectiveness, safety, and guidelines
2014     Technology Assessment Unit of the McGill University Health Centre (MUHC) Excimer laser atherectomy for uncrossable coronary lesions and improperly deployed coronary stents
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Use of chlorhexidine gluconate with alcohol for the prevention of peripheral intravenous device infections: a review of clinical and cost effectiveness, and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Long-term sustained clinical remission after stopping first-line anti-TNF agents in patients with rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis: clinical effectiveness
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Dehumidifiers for reduction of humidity in operating rooms: clinical effectiveness and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Screening tools to identify adults with cognitive impairment associated with a neurological impairment: diagnostic accuracy
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) KRAS testing for metastatic colorectal cancer using therascreen KRAS RGQ PCR kit
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Naloxone prescribing: guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Aclidinium bromide (Tudorza Genuair - Almirall Canada Ltd.) indication: chronic obstructive pulmonary disease
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Developmental effects of in utero exposure to prescription drug abuse in infants and young children: harms
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) High-fidelity simulation training for health care professionals: cost effectiveness and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Slow-release opioids for postoperative pain: clinical effectiveness
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Appropriate use of hand-held wireless devices in healthcare settings: guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Prolotherapy for the management of musculoskeletal pain: a review of the clinical effectiveness
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Bivalirudin infusion following angioplasty: safety
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Brain electrical activity mapping for diagnosing psychiatric disorders: a review of the clinical evidence
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Rivaroxaban (Xarelto- Bayer Inc.) new Indication: pulmonary embolism